Polymorphisms in Plasmodium falciparum K13-propeller in angola and mozambique after the introduction of the ACTs

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Escobar, Carlos ^a,b   Pateira, Sara ^b   Lobo, Elsa ^b,c   Lobo, Lis ^b,c   Teodosio, Rosa ^b   Dias, Fernanda ^d   Fernandes, Natercia ^c   Arez, Ana Paula ^b   Varandas, Luis ^b   Nogueira, Fatima ^b  

^a Hospital Prof Doutor Fernando Fonseca EPE   (Portugal)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d Universidade Agostinho Neto   (Angola)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE; PROTOZOAL PROTEIN;

AMINO ACID SUBSTITUTION; ANGOLA; ANTIMICROBIAL THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GENE MUTATION; MICROBIAL GENE; MOZAMBIQUE; NUCLEIC ACID BASE SUBSTITUTION; PLASMODIUM FALCIPARUM; PROPELLER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG RESISTANCE; GENETICS; GENOTYPE; HUMAN; MALARIA, FALCIPARUM; MUTATION; PARASITOLOGY; PATHOGENICITY;

PLASMODIUM FALCIPARUM;

ANGOLA; ARTEMISININS; DRUG RESISTANCE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MOZAMBIQUE; MUTATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 84925727402     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119215     Document Type: Article

References (15)

1. WHO (2014) Status report on artemisin resistance - September 2014. Available: http://www.who.int/malaria/publications/atoz/status-rep-artemisinin-resistance-sep2014.pdf
2. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, et al. Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2014 Sep 1. pii: jiu491. PMID: 25180241
3. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002; 2:209-218. PMID: 11937421
4. Ministerio de Saúde da República de Moc¸ambique (2011) Plano estratégico da Malaria 2012-2016. Available: http://www.nationalplanningcycles.org/planning-cycle/MOZ. Accessed 24 November 2014.
5. DHS program (2011) Angola - Inquérito de indicadores da malaria. Available: http://dhsprogram.com/pubs/pdf/MIS10/MIS10.pdf. Accessed 24 November 2014.
6. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014; 505(7481):50-5. doi: 10.1038/nature12876 PMID: 24352242
7. Amambua-Ngwa A, Tetteh KK, Manske M, Gomez-Escobar N, Stewart LB, Deerhake ME, et al. Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites. PLoS Genet. 2012; 8(11):e1002992. doi: 10.1371/journal.pgen.1002992 PMID: 23133397
8. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, et al. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014; 9(8):e105690. doi: 10.1371/journal.pone.0105690 PMID: 25144768
9. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study. J Infect Dis. 2014;Sep 1. pii: jiu467. PMID: 25180240
10. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2014;Nov 2. pii: jiu608 PMID: 25367300
11. Fernandes N, Figueiredo P, do Rosário VE, Cravo P. Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant. Malar J. 2007; 6:35. PMID: 17378942
12. Figueiredo P, Benchimol C, Lopes D, Bernardino L, Rosario V, Varandas L, et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar J. 2008; 7:236. doi: 10.1186/1475-2875-7-236 PMID: 19014684
13. Lobo E, Sousa B, Rosa S, Figueiredo P, Lobo L, Pateira S, et al. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisin-based combination therapy. Malaria J. 2014; 13:300. doi: 10.1186/1475-2875-13-300 PMID: 25098280
14. Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, et al. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2014; 91(1):54-61. doi: 10.4269/ajtmh.13-0647 PMID: 24799371
15. Sisowath C, Petersen I, Veiga MI, Mårtensson A, Premji Z, Bjorkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible Pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009; 199:750-7. doi: 10.1086/596738 PMID: 19210165